Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins and cognitive function in the elderly: the Cardiovascular Health Study.

C Bernick1, R Katz, N L Smith

  • 1Department of Medicine, University of Nevada School of Medicine, Las Vegas, NV 89102, USA. cbernick@med.unr.edu

Neurology
|November 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardization of <sup>243</sup>Am.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same author

Considerations for massic activity determination by Decay Energy Spectrometry (DES) using cryogenic Transition Edge Sensors (TES).

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same author

Head trauma in sports - clinical characteristics, epidemiology and biomarkers.

Journal of internal medicine·2018
Same author

Trans-ethnic analysis of metabochip data identifies two new loci associated with BMI.

International journal of obesity (2005)·2018
Same author

Prevalence of Traumatic Findings on Routine MRI in a Large Cohort of Professional Fighters.

AJNR. American journal of neuroradiology·2017
Same author

Generalization and fine mapping of European ancestry-based central adiposity variants in African ancestry populations.

International journal of obesity (2005)·2016
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
Same journal

Cerebral Artery Pulsatility, Premorbid Blood Pressure, and Small Vessel Disease on Brain Imaging: A Population-Based Study.

Neurology·2026
Same journal

Genetic Risk for Alzheimer Disease, Midlife Hypertension, and Dementia: The ARIC Neurocognitive Study.

Neurology·2026
Same journal

What is the Relevance of Neuron-Tumor Interactions in Malignant CNS Tumors?

Neurology·2026
See all related articles

Statin drug use may slightly slow cognitive decline in older adults. This effect on cognition was observed independently of cholesterol-lowering benefits, though MRI changes were not significantly impacted.

Area of Science:

  • Gerontology
  • Neuroscience
  • Pharmacology

Background:

  • Cognitive decline is a significant concern in aging populations.
  • Statins are widely prescribed cholesterol-lowering medications.
  • The impact of statins on cognitive function in the elderly remains an area of active research.

Purpose of the Study:

  • To investigate the association between statin use and changes in cognitive function and brain structure (MRI) in older adults.
  • To determine if statin's effects on cognition are independent of their lipid-lowering properties.

Main Methods:

  • Analysis of data from the Cardiovascular Health Study, a longitudinal study of individuals aged 65 and older.
  • Classification of participants into continuous statin users, intermittent users, and non-users.

Related Experiment Videos

  • Assessment of cognitive decline using the Modified Mini-Mental State Examination (3MS) over 7 years and MRI-based white matter changes and atrophy over 5 years.
  • Exclusion of participants with stroke, TIA, or very low baseline cognitive scores.

    • Main Results:

    • Statin users showed a trend towards a slower rate of cognitive decline (0.48-0.49 points/year less on 3MS) compared to untreated groups, even after controlling for cholesterol levels.
    • No significant differences were found in white matter grade changes or brain atrophy measures between statin users and non-users on MRI.
    • The beneficial effect on cognition was statistically significant in one comparison group (p=0.009).

    Conclusions:

    • Statin drug use is associated with a modest reduction in cognitive decline among the elderly.
    • The observed cognitive benefits of statins may not be solely attributable to their cholesterol-lowering effects.
    • Further research is needed to elucidate the mechanisms behind statin's potential neuroprotective effects.